A comparison of COVID-19, SARS and MERS

Hu T, Liu Y, Zhao M, Zhuang Q, Xu L, He Q.

How lessons learned from the 2015 MERS outbreak affected the effective response to the COVID-19 epidemic in the Republic of Korea

Yang TU, Noh JY, Song JY, Cheong HJ, Kim WJ.

From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses

Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y.

Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: An opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2

da Silva PG, Mesquita JR, de São José Nascimento M, Ferreira VAM.

H1N1 Influenza Virus in Patients With Cystic Fibrosis: A Literature Review Examining Both Disease Entities and Their Association in Light of the 2009 Pandemic

Wiltshire DA, Vahora IS, Tsouklidis N, Kumar R, Khan S.

Preventing influenza and influenza like illness during Covid-19 pandemic: A call for action

d'Ettorre G, Ceccarelli G, Pinacchio C, Ciccozzi M, d'Ettorre G.

COVID-19: Lessons from SARS and MERS

Park M, Thwaites RS, Openshaw PJM.

Simultaneous circulation of COVID-19 and flu in Italy: potential combined effects on the risk of death?

Capone A.

SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus

Dhama K, Patel SK, Sharun K, Pathak M, Tiwari R, Yatoo MI, Malik YS, Sah R, Rabaan AA, Panwar PK, Singh KP, Michalak I, Chaicumpa W, Martinez-Pulgarin DF, Bonilla-Aldana DK, Rodriguez-Morales AJ.

Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us

Kumar V.

Clinical characteristics of COVID-19 and its comparison with influenza pneumonia

Qu J, Chang LK, Tang X, Du Y, Yang X, Liu X, Han P, Xue Y.

Systematic testing for influenza and COVID-19 among patients with respiratory illness

Flannery B, Meece JK, Williams JV, Martin ET, Gaglani M, Jackson ML, Talbot HK.

Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger!

Habtemariam S, Berindan-Neagoe I, Cismaru CA, Schaafsma D, Nabavi SF, Ghavami S, Banach M, Nabavi SM.

From H1N1 to 2019-nCoV, what do we learn?

Liu GE, Tian Y, Zhao WJ, Song SM, Li L.

Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan

Hirotsu Y, Maejima M, Shibusawa M, Amemiya K, Nagakubo Y, Hosaka K, Sueki H, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M.

Changes in population movement make COVID-19 spread differently from SARS

Shi Q, Dorling D, Cao G, Liu T.

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Park SH, Choi JY, Kim SH, Jung I, Shin EC.

Lessons From History: What Can We Learn From 300 Years of Pandemic Flu That Could Inform the Response to COVID-19?

Esparza J.

SARS, MERS, COVID-19: Clinical Manifestations and Organ-System Complications: A Mini Review

Harb JG, Noureldine HA, Chedid G, Eldine MN, Abdallah DA, Chedid NF, Nour-Eldine W.

Coinfection with SARS-CoV-2 and influenza A virus

Kondo Y, Miyazaki S, Yamashita R, Ikeda T.

Prevalence of Flu-like Symptoms and COVID-19 in Healthcare Workers from India

Jha S, Soni A, Siddiqui S, Batra N, Goel N, Dey S, Budhiraja S, Naithani R.

Comparative analysis of coronavirus genomic RNA structure reveals conservation in SARS-like coronaviruses

Sanders W, Fritch EJ, Madden EA, Graham RL, Vincent HA, Heise MT, Baric RS, Moorman NJ.

COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia

Langerbeins P, Fürstenau M, Gruell H, Klein F, Persigehl T, Rybniker J, Seeger-Nukpezah T, Kochanek M, Hallek M, Eichhorst B, Koehler P, Böll B.

Comparative Analysis of Early-Stage Clinical Features Between COVID-19 and Influenza A H1N1 Virus Pneumonia

Shen C, Tan M, Song X, Zhang G, Liang J, Yu H, Wang C.

COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS

Gibson PG, Qin L, Puah SH.

Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis

Zhou Q, Gao Y, Wang X, Liu R, Du P, Wang X, Zhang X, Lu S, Wang Z, Shi Q, Li W, Ma Y, Luo X, Fukuoka T, Ahn HS, Lee MS, Liu E, Chen Y, Luo Z, Yang K; COVID-19 Evidence and Recommendations Working Group.

Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature

Alessandra D, Lepore L, Palazzolo C, Barreca F, Giuseppina L, Eleonora L, Emanuele N.

Neurological manifestations of COVID-19, SARS and MERS

Kato V, Laure B, Harald C.

A Municipality-Based Approach Using Commuting Census Data to Characterize the Vulnerability to Influenza-Like Epidemic: The COVID-19 Application in Italy

Savini L, Candeloro L, Calistri P, Conte A.

MERS-CoV and SARS-CoV infections in animals: a systematic review and meta-analysis of prevalence studies

Bonilla-Aldana DK, Cardona-Trujillo MC, García-Barco A, Holguin-Rivera Y, Cortes-Bonilla I, Bedoya-Arias HA, Patiño-Cadavid LJ, Tamayo-Orozco JD, Paniz-Mondolfi A, Zambrano LI, Dhama K, Sah R, Rabaan AA, Balbin-Ramon GJ, Rodriguez-Morales AJ.

Preparing for emerging respiratory pathogens such as SARS-CoV, MERS-CoV, and SARS-CoV-2

Al-Tawfiq JA, Garout MA, Gautret P.

Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19

Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS.

Could SARS-CoV-2/COVID-19 simply fade away?

Rosselli D, Yucumá D, Rodríguez-Morales AJ, Esposito S.

Are co-infections with COVID-19 and Influenza low or underreported? An observational study examining current published literature including three new unpublished cases

Antony SJ, Almaghlouth NK, Heydemann EL.

COVID-19 and flu, a perfect storm

Belongia EA, Osterholm MT.

The Dual Epidemics of COVID-19 and Influenza: Vaccine Acceptance, Coverage, and Mandates

Gostin LO, Salmon DA.

A Case Series of Patients Coinfected With Influenza and COVID-19

Konala VM, Adapa S, Naramala S, Chenna A, Lamichhane S, Garlapati PR, Balla M, Gayam V.

Impact of COVID-19 public health interventions on influenza incidence in Thailand

Suntronwong N, Thongpan I, Chuchaona W, Budi Lestari F, Vichaiwattana P, Yorsaeng R, Pasittungkul S, Kitphati R, Vongpunsawad S, Poovorawan Y.

[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).]

Lvov DK, Alkhovsky SV.

Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2

İnandıklıoğlu N, Akkoc T.

COVID-19 versus seasonal influenza 2019-2020: USA

Wormser GP.

Using the COVID-19 to influenza ratio to estimate the numbers of symptomatic COVID-19 cases in Wuhan prior to the lockdown

Du Z, Cowling BJ, Meyers LA.

Assessing the interactions between COVID-19 and influenza in the United States

Zipfel CM, Bansal S.

Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease

Mudd PA, Crawford JC, Turner JS, Souquette A, Reynolds D, Bender D, Bosanquet JP, Anand NJ, Striker DA, Martin RS, Boon ACM, House SL, Remy KE, Hotchkiss RS, Presti RM, OHalloran JA, Powderly WG, Thomas PG, Ellebedy AH.

Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza

Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS, Kahan J, Lansdale KN, LeMoss NM, Murthy SB, Stieg PE, Fink ME, Iadecola C, Segal AZ, Campion TR, Diaz I, Zhang C, Navi BB.

Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2

Mick E, Kamm J, Pisco AO, Ratnasiri K, Babik JM, Calfee CS, Castaneda G, DeRisi JL, Detweiler AM, Hao S, Kangelaris KN, Kumar GR, Li LM, Mann SA, Neff N, Prasad PA, Serpa PH, Shah SJ, Spottiswoode N, Tan M, Christenson SA, Kistler A, Langelier C.

An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza

Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrah√£o MTF, Alberga A, Alghoul H, Alser O, Alshammari TM, Areia C, Banda JM, Cho J, Culhane AC, Davydov A, DeFalco FJ, Duarte-Salles T, DuVall S, Falconer T, Gao W, Golozar A, Hardin J, Hripcsak G, Huser V, Jeon H, Jing Y, Jung CY, Kaas-Hansen BS, Kaduk D, Kent S, Kim Y, Kolovos S, Lane JCE, Lee H, Lynch KE, Makadia R, Matheny ME, Mehta P, Morales DR, Natarajan K, Nyberg F, Ostropolets A, Park RW, Park J, Posada JD, Prats-Uribe A, Rao G, Reich C,

Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis

Pormohammad A, Ghorbani S, Khatami A, Farzi R, Baradaran B, Turner DL, Turner RJ, Bahr NC, Idrovo JP.

Historical Insights on Coronavirus Disease 2019 (COVID-19), the 1918 Influenza Pandemic, and Racial Disparities: Illuminating a Path Forward

Krishnan L, Ogunwole SM, Cooper LA.

Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature

Ozaras R, Cirpin R, Duran A, Duman H, Arslan O, Bakcan Y, Kaya M, Mutlu H, Isayeva L, Kebanlı F, Deger BA, Bekeshev E, Kaya F, Bilir S.

Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza

Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, Guo F, Zhang X, Luo R, Huang C, Lu H, Zheng B, Zhang J, Yan R, Zhang H, Jiang H, Xu Q, Guo J, Gong Y, Tang L, Li L.

Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus

Xu P, Sun GD, Li ZZ.

SARS, MERS and COVID-19 among healthcare workers: A narrative review

Xiao J, Fang M, Chen Q, He B.

Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" Nutrients 2020, 12(4), 988

Kow CS, Hadi MA, Hasan SS.

Reply: "Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988"

Grant WB, Baggerly CA, Lahore H.

Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020

Itaya T, Furuse Y, Jindai K.

COVID-19 versus the 1918 influenza pandemic: different virus, different age mortality patterns

Shanks GD.

Differentiating Between 2019 Novel Coronavirus Pneumonia and Influenza Using a Nonspecific Laboratory Marker-Based Dynamic Nomogram

Wang L, Liu Y, Zhang T, Jiang Y, Yang S, Xu Y, Song R, Song M, Wang L, Zhang W, Han B, Yang L, Fan Y, Cheng C, Wang J, Xiang P, Pu L, Xiong H, Li C, Zhang M, Tan J, Chen Z, Liu J, Wang X.

Severe Complicated Influenza Declined During the Prevention of COVID-19 in Taiwan

Yang CJ, Chen TC, Kuo SH, Hsieh MH, Chen YH.

Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19?

Gutman JR, Lucchi NW, Cantey PT, Steinhardt LC, Samuels AM, Kamb ML, Kapella BK, McElroy PD, Udhayakumar V, Lindblade KA.

From SARS to COVID-19: the Singapore journey

Lin RJ, Lee TH, Lye DC.

Monitoring COVID-19 through Trends in Influenza-like Illness and Laboratory-confirmed Influenza and COVID-19 - New York State, excluding New York City, January 1 - April 12, 2020

Rosenberg ES, Hall EW, Rosenthal EM, Maxted AM, Gowie DL, Dufort EM, Blog DS, Hoefer D, St George K, Hutton BJ, Zucker HA; New York State Coronavirus 2019 Response Team.

Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China

Zheng X, Wang H, Su Z, Li W, Yang D, Deng F, Chen J.

COVID-19 Patients with Recent Influenza A/B Infection: A Retrospective Study

Wu P, Lu W, He L, Meng Y, Wu P, Ding W, Ma K, Liu J.

Co-infections in people with COVID-19: a systematic review and meta-analysis

Lansbury L, Lim B, Baskaran V, Lim WS.

Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea

Lee H, Lee H, Song KH, Kim ES, Park JS, Jung J, Ahn S, Jeong EK, Park H, Kim HB.

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike

Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, Xin S, Cao P, Lu J.

Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China

Ma S, Lai X, Chen Z, Tu S, Qin K.

Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?

Sánchez-Duque JA, Orozco-Hernández JP, Marín-Medina DS, Cvetkovic-Vega A, Aveiro-Róbalo TR, Mondragon-Cardona A, Failoc-Rojas VE, Gutiérrez-Ocampo E, Villamizar-Peña R, Henao-Martínez JF, Arteaga-Livias K, Rodríguez-Morales AJ.

Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China

Li ZT, Chen ZM, Chen LD, Zhan YQ, Li SQ, Cheng J, Zhu AR, Chen LY, Zhong NS, Li SY, Lu WJ, Ye F.

[COVID-19, Influenza and Economic Activity - An Impact Analysis Perspective]

Winkler A.

A Comparison of Clinical and Chest CT Findings in Patients With Influenza A (H1N1) Virus Infection and Coronavirus Disease (COVID-19)

Yin Z, Kang Z, Yang D, Ding S, Luo H, Xiao E.

Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience

Algaissi AA, Alharbi NK, Hassanain M, Hashem AM.

Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis

Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, Eyre L, Breen A, O'Connor RJ, Jones A, Sivan M.

Different patterns of Influenza A and B detected during early stages of COVID-19 in a university hospital in S√£o Paulo, Brazil

Luna LKS, Perosa DAH, Conte DD, Carvalho JMA, Alves VRG, Cruz JS, Bellei N.

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Ma C, Su S, Wang J, Wei L, Du L, Jiang S.

A novel coronavirus (SARS-CoV-2) and COVID-19

Trojánek M, Grebenyuk V, Herrmannová K, Nečas T, Gregorová J, Kucbel M, Šín R, Roháčová H, Stejskal F.

Reply: COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency

Luks AM, Swenson ER.

COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency

Kyle-Sidell C.

SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review

Nascimento Junior JAC, Santos AM, Quintans-J√∫nior LJ, Walker CIB, Borges LP, Serafini MR.

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections

Lv H, Wu NC, Tak-Yin Tsang O, Yuan M, Perera RAPM, Leung WS, So RTY, Chun Chan JM, Yip GK, Hong Chik TS, Wang Y, Chung Choi CY, Lin Y, Ng WW, Zhao J, Poon LLM, Peiris JSM, Wilson IA, Mok CKP.

Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS

Li B, Jin X, Zhang T, Zhao Y, Tian F, Li Y, Yang J, Zhao F, Li B.

A Case Report of Oligosymptomatic Kidney Transplant Patients with COVID-19: Do They Pose a Risk to Other Recipients?

Kocak B, Arpali E, Akyollu B, Yelken B, Tekin S, Kanbay M, Turkmen A, Kalayoglu M.

COVID-19, SARS and MERS: A neurological perspective

Ng Kee Kwong KC, Mehta PR, Shukla G, Mehta AR.

Free DNA, a reason for severe COVID-19 infection?

Liu B.

Co-infection with COVID-19 and Influenza A Virus in two died patients with Acute Respiratory Syndrome, Bojnurd, Iran.

Hashemi SA, Safamanesh S, Ghafouri M, Taghavi MR, Mohajeri Zadeh Heydari MS, Abad HNA, Zadeh-Moghadam HG, Amir A.

Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?

Lyons D, Frampton M, Naqvi S, Donohoe D, Adams G, Glynn K.

COVID-19 and the 'Spanish' flu.

Plagues, pandemics and epidemics in Irish history prior to COVID-19 (coronavirus): what can we learn?

COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.

Co-infection with Influenza A and COVID-19.

A Case of Coinfection with SARS-COV-2 and Cytomegalovirus in the Era of COVID-19.

Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2.

Co-infection of SARS CoV-2 and influenza A in a Pediatric Patient in Germany.

Wehl G, Laible M, Rauchenzauner M.

From SARS to COVID-19: What we have learned about children infected with COVID-19.

COVID-19 and Middle East Respiratory Syndrome Infections in Health-Care Workers in Korea.

Kang SK.

What I Learned From SARS in 2003 That Will Help Me Cope With COVID-19 in 2020.

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.

Acute respiratory failure in COVID-19: is it "typical" ARDS?

Li X, Ma X.

Case Report: Diagnosis of Novel Coronavirus Disease (COVID-19) versus Tropical Diseases in Pakistan.

Bokhari SMMA, Mahmood F, Bokhari SMSA.

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.

Li H, Chen C, Hu F, Wang J, Zhao Q, Gale RP, Liang Y.

Differentiating COVID-19 Pneumonia from Acute Respiratory Distress Syndrome (ARDS) and High Altitude Pulmonary Edema (HAPE): Therapeutic Implications.

Archer SL, Sharp WW, Weir EK.

Co-infection with SARS-CoV-2 and influenza A virus.

Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report.

Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.

Liya G, Yuguang W, Jian L, Huaiping Y, Xue H, Jianwei H, Jiaju M, Youran L, Chen M, Yiqing J.

SARS, MERS and COVID-19-new threats; old lessons.

Gilbert GL.

100 years of influenza research seen through the lens of Covid-19.

Bogaert D, Dockrell DH.

Co-infection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?

Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE.

Pediatric SARS, H1N1, MERS, EVALI, and Now Coronavirus Disease (COVID-19) Pneumonia: What Radiologists Need to Know.

Foust AM, Winant AJ, Chu WC, Das KM, Phillips GS, Lee EY.

Commentary on: The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? A One Health approach to coronaviruses.

Kahn LH.

[Comparison of epidemiological and clinical characteristics of SARS, pandemic (H1N1) 2009 and COVID-19, and consideration on prevention and control strategies of COVID-19].

Wang HQ.

INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.

Schwartz DA, Dhaliwal A.

Role of Telehealth in the Management of COVID-19: Lessons Learned from Previous SARS, MERS, and Ebola Outbreaks.

Keshvardoost S, Bahaadinbeigy K, Fatehi F.

The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.

da Costa VG, Moreli ML, Saivish MV.

COVID-19: searching for clues among other respiratory viruses.

Nguyen-Robertson C, Haque A, Mintern J, La Flamme AC.

Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.

Giannis D, Ziogas IA, Gianni P.

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.

Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, de Meulder D, van Amerongen G, van den Brand J, Okba NMA, Schipper D, van Run P, Leijten L, Sikkema R, Verschoor E, Verstrepen B, Bogers W, Langermans J, Drosten C, Fentener van Vlissingen M, Fouchier R, de Swart R, et al.

SARS-CoV-2 and COVID-19.

Sheng WH, Ko WC, Huang YC, Hsueh PR.

[What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].

Liu YJ, Yang YL, Xu Y.

Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated.

Chaung J, Chan D, Pada S, Tambyah PA.

Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.

Kim D, Quinn J, Pinsky B, Shah NH, Brown I.

Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis.

Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, Vecchiet J, Nappi L, Scambia G, Berghella V, D'Antonio F.

Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China.

Zhang J, Lin G, Zeng J, Lin J, Tian J, Li G.

COVID-19: A promising cure for the global panic.

Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, Ganesan S, Venugopal A, Venkatesan D, Ganesan H, Rajagopalan K, Rahman PKSM, Cho SG, Kumar NS, Subramaniam MD.

Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS.

Liang K.

COVID-19 and SARS: differences and similarities.

Antonio C, Claudio C, Nicola DM, Caterina D, Jafferany M, Lotti T, Zalaudek I, Giuffrida R.

SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview

Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, Dhama K, Yatoo MI, Bonilla-Aldana DK, Rodriguez-Morales AJ.

[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].

Ding YQ, Bian XW.

Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.

Rokni M, Ghasemi V, Tavakoli Z.

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.

Lin Q, Zhu L, Ni Z, Meng H, You L.

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

Jiang S, Hillyer C, Du L.

The

in COVID-19 patients undergoing non invasive ventilation.

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy.

Al-Tawfiq JA.

Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2?

Henrickson SE.

A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV.

Yuan M, Wu NC, Zhu X, Lee CD, So RTY, Lv H, Mok CKP, Wilson IA.

[From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment].

Wang X, Ding YQ.

Follow-up of asymptomatic patients with SARS-CoV-2 infection.

Zhou X, Li Y, Li T, Zhang W.

COVID-19, SARS and MERS: are they closely related?

Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E.

Multi-omics Evaluation of Gastrointestinal and Other Clinical Characteristics of SARS-CoV-2 and COVID-19.

Du M, Cai G, Chen F, Christiani DC, Zhang Z, Wang M.

How to surge to face SARS-CoV-2 outbreak. Lessons learned from Lumbardy, Italy.

Faccincani R, Pascucci F, Lennquist S.

Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak.

Tay JK, Khoo ML, Loh WS.

Forty years with coronaviruses.

Weiss SR.

Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1.

Tang X, Du R, Wang R, Cao T, Guan L, Yang C, Zhu Q, Hu M, Li X, Li Y, Liang L, Tong Z, Sun B, Peng P, Shi H.

A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.

Zhang YZ, Holmes EC.

SARS-CoV-2 and HIV.

Joob B, Wiwanitkit V.

SARS-CoV-2: What do we know so far?

Khedkar PH, Patzak A.

The SARS-CoV-2 Vaccine Pipeline: an Overview.

Chen WH, Strych U, Hotez PJ, Bottazzi ME.

Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins.

Lam TT, Shum MH, Zhu HC, Tong YG, Ni XB, Liao YS, Wei W, Cheung WY, Li WJ, Li LF, Leung GM, Holmes EC, Hu YL, Guan Y.

Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.

Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W, Narykov O, Sun M, Korkin D.

Strengthening China's Public Health Response System: From SARS to COVID-19.

Bouey J.

Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).

Kumar S, Maurya VK, Prasad AK, Bhatt MLB, Saxena SK.

From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans - Call for a One Health approach.

El Zowalaty ME, Järhult JD.

Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?

Al-Tawfiq JA.

COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia.

Barry M, Al Amri M, Memish ZA.

Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients.

Lin D, Liu L, Zhang M, Hu Y, Yang Q, Guo J, Guo Y, Dai Y, Xu Y, Cai Y, Chen X, Zhang Z, Huang K.

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias.

Zhao D, Yao F, Wang L, Zheng L, Gao Y, Ye J, Guo F, Zhao H, Gao R.

Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.

Wu X, Cai Y, Huang X, Yu X, Zhao L, Wang F, Li Q, Gu S, Xu T, Li Y, Lu B, Zhan Q.

[Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou].

Li XQ, Cai WF, Huang LF, Chen C, Liu YF, Zhang ZB, Yuan J, Li TG, Wang M.

From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.

Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M.

Effectiveness for the Response to COVID-19: The MERS Outbreak Containment Procedures.

Cho HW.

Can we contain the COVID-19 outbreak with the same measures as for SARS?

Wilder-Smith A, Chiew CJ, Lee VJ.

Authors' response: Plenty of coronaviruses but no SARS-CoV-2.

Reusken CB, Haagmans B, Meijer A, Corman VM, Papa A, Charrel R, Drosten C, Koopmans M.

Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2.

Colson P, La Scola B, Esteves-Vieira V, Ninove L, Zandotti C, Jimeno MT, Gazin C, Bedotto M, Filosa V, Giraud-Gatineau A, Chaudet H, Brouqui P, Lagier JC, Raoult D.

From SARS-CoV to 2019-nCoV Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends.

Chen ZL, Zhang WJ, Lu Y, Guo C, Guo ZM, Liao CH, Zhang X, Zhang Y, Han XH, Li QL, Lu JH.

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV.

Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, Wang Y, Guo X.

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W, Haque U.

Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate.

Mahase E.

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.

Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U, Yang D.

Does SARS-CoV-2 has a longer incubation period than SARS and MERS?

Jiang X, Rayner S, Luo MH.

Three Emerging Coronaviruses in Two Decades.

Guarner J.

Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV.

Lee PI, Hsueh PR.

Origins of MERS-CoV, and lessons for 2019-nCoV.

Ji JS.